United Therapeutics Company Profile (NASDAQ:UTHR)

About United Therapeutics

United Therapeutics logoUnited Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. Its therapeutic products and product candidates include Prostacyclin Analogues, Phosphodiesterase Type 5 (PDE-5) Inhibitor and Monoclonal Antibody (MAb). Its Prostacyclin Analogues lead product is Remodulin (treprostinil) Injection. It also includes Tyvaso (treprostinil) Inhalation Solution and Orenitram (treprostinil) Extended-Release Tablets. Its subsidiary is developing another oral prostacyclin analogue for the treatment of pulmonary arterial hypertension (PAH) called esuberaprost. Its PDE-5 inhibitor is Adcirca (tadalafil) tablets are indicated for the treatment of PAH. Its Unituxin (dinutuximab) Injection in combination with granulocyte-macrophage colony-stimulating factor, interleukin-2 and 13-cis-retinoic acid is indicated for the treatment of pediatric patients with neuroblastoma.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: UTHR
  • CUSIP: 91307C10
Key Metrics:
  • Previous Close: $167.92
  • 50 Day Moving Average: $156.86
  • 200 Day Moving Average: $133.52
  • 52-Week Range: $97.52 - $169.89
  • Trailing P/E Ratio: 11.36
  • Foreward P/E Ratio: 11.68
  • P/E Growth: -4.51
  • Market Cap: $7.12B
  • Outstanding Shares: 42,415,000
  • Beta: 1.42
Profitability:
  • Net Margins: 44.40%
  • Return on Equity: 41.78%
  • Return on Assets: 32.80%
Debt:
  • Current Ratio: 4.41%
  • Quick Ratio: 4.11%
Additional Links:
Companies Related to United Therapeutics:

Analyst Ratings

Consensus Ratings for United Therapeutics (NASDAQ:UTHR) (?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $134.18 (20.09% downside)

Analysts' Ratings History for United Therapeutics (NASDAQ:UTHR)
Show:
DateFirmActionRatingPrice TargetDetails
2/14/2017Oppenheimer Holdings, Inc.Reiterated RatingBuyView Rating Details
2/8/2017WedbushReiterated RatingOutperform$229.00View Rating Details
1/19/2017Standpoint ResearchDowngradeBuy -> HoldView Rating Details
11/29/2016Barclays PLCDowngradeEqual Weight -> Underweight$115.00 -> $100.00View Rating Details
10/27/2016Cowen and CompanySet Price TargetBuy$144.00View Rating Details
10/28/2016Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$128.00 -> $138.00View Rating Details
8/23/2016ArgusReiterated RatingHoldView Rating Details
7/29/2016J P Morgan Chase & CoLower Price TargetNeutral$145.00 -> $129.00View Rating Details
7/29/2016Jefferies Group LLCReiterated RatingHold$120.00View Rating Details
7/29/2016HC WainwrightReiterated RatingHoldView Rating Details
4/16/2016Leerink SwannReiterated RatingMarket PerformView Rating Details
4/11/2016Royal Bank Of CanadaReiterated RatingSector Perform$150.00 -> $122.00View Rating Details
7/20/2015Goldman Sachs Group, Inc. (The)Lower Price TargetSell$98.00 -> $95.00View Rating Details
5/18/2015BTIG ResearchUpgradeNeutral -> Buy$225.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for United Therapeutics (NASDAQ:UTHR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/23/2017        
2/22/2017Q416$3.61$2.49$415.51 million$409.00 millionN/AView Earnings Details
10/27/2016Q316$3.38$4.36$400.58 million$408.20 millionViewListenView Earnings Details
7/28/2016Q216$3.22$4.55$395.15 million$412.60 millionViewListenView Earnings Details
4/28/2016Q116$3.21$3.02$395.02 million$369.00 millionViewListenView Earnings Details
2/25/2016Q415$2.70$3.68$388.29 million$404.90 millionViewListenView Earnings Details
10/27/2015Q315$2.35$3.55$363.51 million$386.20 millionViewListenView Earnings Details
7/28/2015Q215$2.31$2.55$360.41 million$347.20 millionViewListenView Earnings Details
4/28/2015Q115$2.14$2.55$353.50 million$327.60 millionViewN/AView Earnings Details
2/24/2015Q414$2.03$3.21$336.22 million$346.40 millionViewN/AView Earnings Details
10/28/2014Q314$1.97$3.91$335.10 million$330.00 millionViewN/AView Earnings Details
7/29/2014Q214$1.75$2.57$308.04 million$322.80 millionViewN/AView Earnings Details
4/29/2014Q114$1.65$1.77$300.14 million$289.40 millionViewN/AView Earnings Details
2/25/2014Q413$1.51$2.88$295.43 million$289.02 millionViewN/AView Earnings Details
10/29/2013Q313$1.59$2.98$279.02 million$302.20 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.47$1.52$250.17 million$280.60 millionViewN/AView Earnings Details
4/25/2013Q1 2013$1.47$1.19$241.14 million$245.14 millionViewN/AView Earnings Details
2/26/2013Q4 2012$1.25$1.65$233.41 million$243.82 millionViewN/AView Earnings Details
11/1/2012Q312$1.26$2.82$227.63 million$242.50 millionViewN/AView Earnings Details
7/26/2012$1.23$1.34ViewN/AView Earnings Details
4/26/2012$1.00$1.32ViewN/AView Earnings Details
2/14/2012$0.85$0.77ViewN/AView Earnings Details
10/27/2011$0.88$1.32ViewN/AView Earnings Details
7/28/2011$0.49$1.27ViewN/AView Earnings Details
4/28/2011$0.64$1.29ViewN/AView Earnings Details
2/15/2011$0.62$0.15ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for United Therapeutics (NASDAQ:UTHR)
Current Year EPS Consensus Estimate: $16.23 EPS
Next Year EPS Consensus Estimate: $14.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$2.59$2.98$2.79
Q2 20163$3.05$3.55$3.22
Q3 20163$3.10$3.35$3.19
Q4 20164$3.27$3.92$3.49
Q1 20172$3.05$3.07$3.06
Q2 20171$3.15$3.15$3.15
Q3 20171$3.32$3.32$3.32
Q4 20171$3.31$3.31$3.31
(Data provided by Zacks Investment Research)

Dividends

Dividend History for United Therapeutics (NASDAQ:UTHR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for United Therapeutics (NASDAQ:UTHR)
Insider Ownership Percentage: 7.50%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/16/2017Martine A RothblattCEOSell1,173$167.92$196,970.16View SEC Filing  
1/12/2017Christopher PatuskyDirectorSell5,000$141.99$709,950.00View SEC Filing  
1/12/2017Martine A RothblattCEOSell1,214$142.37$172,837.18View SEC Filing  
1/5/2017Martine A RothblattCEOSell1,208$145.73$176,041.84View SEC Filing  
12/29/2016Martine A RothblattCEOSell1,211$143.63$173,935.93View SEC Filing  
12/22/2016Martine A RothblattCEOSell1,218$140.23$170,800.14View SEC Filing  
12/15/2016Martine A RothblattCEOSell1,212$143.11$173,449.32View SEC Filing  
12/8/2016Martine A RothblattCEOSell1,236$131.78$162,880.08View SEC Filing  
12/6/2016Richard GiltnerDirectorSell5,000$133.37$666,850.00View SEC Filing  
12/1/2016Martine A RothblattCEOSell1,246$126.86$158,067.56View SEC Filing  
11/25/2016Martine A RothblattCEOSell1,233$132.81$163,754.73View SEC Filing  
11/17/2016Martine A RothblattCEOSell1,232$132.94$163,782.08View SEC Filing  
11/10/2016Christopher PatuskyDirectorSell5,000$131.42$657,100.00View SEC Filing  
11/10/2016Martine A RothblattCEOSell1,240$129.82$160,976.80View SEC Filing  
11/3/2016Martine A RothblattCEOSell1,272$116.94$148,747.68View SEC Filing  
10/27/2016Martine A RothblattCEOSell1,272$117.06$148,900.32View SEC Filing  
10/20/2016Martine A RothblattCEOSell1,282$113.30$145,250.60View SEC Filing  
10/13/2016Martine A RothblattCEOSell1,269$117.99$149,729.31View SEC Filing  
10/6/2016Martine A RothblattCEOSell1,260$121.17$152,674.20View SEC Filing  
9/29/2016Martine A RothblattCEOSell1,272$116.94$148,747.68View SEC Filing  
9/26/2016Tommy G ThompsonDirectorSell1,291$125.57$162,110.87View SEC Filing  
9/22/2016Martine A RothblattCEOSell1,249$125.87$157,211.63View SEC Filing  
9/15/2016Martine A RothblattCEOSell1,258$122.34$153,903.72View SEC Filing  
9/8/2016Martine A RothblattCEOSell1,254$123.44$154,793.76View SEC Filing  
9/1/2016Christopher PatuskyDirectorSell5,000$122.73$613,650.00View SEC Filing  
9/1/2016Martine A RothblattCEOSell1,257$122.81$154,372.17View SEC Filing  
8/25/2016Martine A RothblattCEOSell1,250$125.29$156,612.50View SEC Filing  
8/18/2016Martine A RothblattCEOSell1,249$125.88$157,224.12View SEC Filing  
8/11/2016Martine A RothblattCEOSell1,253$124.09$155,484.77View SEC Filing  
8/4/2016Martine A RothblattCEOSell1,249$125.78$157,099.22View SEC Filing  
7/28/2016Martine A RothblattCEOSell1,271$117.05$148,770.55View SEC Filing  
7/21/2016Martine A RothblattCEOSell1,284$112.77$144,796.68View SEC Filing  
7/14/2016Martine A RothblattCEOSell1,292$110.05$142,184.60View SEC Filing  
7/7/2016Martine A RothblattCEOSell1,293$109.87$142,061.91View SEC Filing  
6/30/2016Martine A RothblattCEOSell1,308$105.10$137,470.80View SEC Filing  
6/23/2016Martine A RothblattCEOSell1,312$104.07$136,539.84View SEC Filing  
6/16/2016Martine A RothblattCEOSell1,308$105.18$137,575.44View SEC Filing  
6/9/2016Martine A RothblattCEOSell1,277$114.99$146,842.23View SEC Filing  
6/8/2016Tommy G ThompsonDirectorSell2,000$115.62$231,240.00View SEC Filing  
6/2/2016Martine A RothblattCEOSell1,261$120.79$152,316.19View SEC Filing  
6/2/2016Raymond DwekDirectorSell3,000$118.82$356,460.00View SEC Filing  
5/26/2016Martine A RothblattCEOSell5,547$117.57$652,160.79View SEC Filing  
5/19/2016Martine A RothblattCEOSell5,546$110.75$614,219.50View SEC Filing  
5/12/2016Martine A RothblattCEOSell5,547$109.02$604,733.94View SEC Filing  
5/12/2016Raymond DwekDirectorSell3,000$110.00$330,000.00View SEC Filing  
5/5/2016Martine A RothblattCEOSell5,546$107.79$597,803.34View SEC Filing  
4/28/2016Martine A RothblattCEOSell5,547$106.81$592,475.07View SEC Filing  
4/21/2016Martine A RothblattCEOSell5,546$115.74$641,894.04View SEC Filing  
4/14/2016Martine A RothblattCEOSell5,547$114.32$634,133.04View SEC Filing  
4/7/2016Martine A RothblattCEOSell5,546$113.31$628,417.26View SEC Filing  
3/24/2016Martine A RothblattCEOSell5,546$110.80$614,496.80View SEC Filing  
3/17/2016Martine A RothblattCEOSell5,547$118.22$655,766.34View SEC Filing  
3/10/2016Martine A RothblattCEOSell5,546$123.41$684,431.86View SEC Filing  
3/3/2016Martine A RothblattCEOSell5,547$126.78$703,248.66View SEC Filing  
2/25/2016Martine A RothblattCEOSell5,546$122.45$679,107.70View SEC Filing  
2/18/2016Martine A RothblattCEOSell5,547$128.26$711,458.22View SEC Filing  
2/11/2016Martine A. RothblattCEOSell5,546$120.47$668,126.62View SEC Filing  
2/4/2016Martine A. RothblattCEOSell5,547$122.13$677,455.11View SEC Filing  
2/4/2016Raymond DwekDirectorSell3,000$122.66$367,980.00View SEC Filing  
1/28/2016Martine A. RothblattCEOSell5,546$124.00$687,704.00View SEC Filing  
1/21/2016Martine A. RothblattCEOSell5,547$127.00$704,469.00View SEC Filing  
1/14/2016Martine A. RothblattCEOSell5,546$135.94$753,923.24View SEC Filing  
1/7/2016Martine A. RothblattCEOSell5,547$145.84$808,974.48View SEC Filing  
1/7/2016Raymond DwekDirectorSell3,000$143.75$431,250.00View SEC Filing  
12/24/2015Martine A. RothblattCEOSell5,546$159.58$885,030.68View SEC Filing  
12/17/2015Martine A. RothblattCEOSell5,546$158.49$878,985.54View SEC Filing  
12/10/2015Martine A. RothblattCEOSell5,546$154.49$856,801.54View SEC Filing  
12/3/2015Martine A. RothblattCEOSell5,546$154.49$856,801.54View SEC Filing  
12/3/2015Raymond DwekDirectorSell3,000$157.22$471,660.00View SEC Filing  
11/27/2015Martine A. RothblattCEOSell5,561$153.81$855,337.41View SEC Filing  
11/19/2015Martine A. RothblattCEOSell9,661$148.56$1,435,238.16View SEC Filing  
11/12/2015Martine A. RothblattCEOSell4,115$147.72$607,867.80View SEC Filing  
11/5/2015Martine A. RothblattCEOSell4,115$149.16$613,793.40View SEC Filing  
11/5/2015Raymond DwekDirectorSell3,000$149.63$448,890.00View SEC Filing  
11/3/2015Richard GiltnerDirectorSell7,500$153.22$1,149,150.00View SEC Filing  
10/29/2015Martine A. RothblattCEOSell9,662$141.89$1,370,941.18View SEC Filing  
10/28/2015Martine A. RothblattCEOSell2,211$136.58$301,978.38View SEC Filing  
10/26/2015Martine A. RothblattCEOSell2,592$127.13$329,520.96View SEC Filing  
10/22/2015Martine A. RothblattCEOSell9,662$122.40$1,182,628.80View SEC Filing  
10/21/2015Martine A. RothblattCEOSell2,211$123.63$273,345.93View SEC Filing  
10/19/2015Martine A. RothblattCEOSell2,592$126.71$328,432.32View SEC Filing  
10/15/2015Martine A. RothblattCEOSell9,662$126.22$1,219,537.64View SEC Filing  
10/14/2015Martine A. RothblattCEOSell2,211$123.53$273,124.83View SEC Filing  
10/12/2015Martine A. RothblattCEOSell2,592$123.51$320,137.92View SEC Filing  
10/8/2015Martine A. RothblattCEOSell9,662$122.48$1,183,401.76View SEC Filing  
10/7/2015Martine A. RothblattCEOSell2,211$120.88$267,265.68View SEC Filing  
10/5/2015Martine A. RothblattCEOSell2,592$126.88$328,872.96View SEC Filing  
10/1/2015Martine A. RothblattCEOSell6,326$131.11$829,401.86View SEC Filing  
10/1/2015Paul A. MahonEVPSell6,000$129.38$776,280.00View SEC Filing  
10/1/2015Raymond DwekDirectorSell3,000$131.32$393,960.00View SEC Filing  
9/29/2015Martine A. RothblattCEOSell2,592$134.25$347,976.00View SEC Filing  
9/29/2015Tommy G. ThompsonDirectorSell5,000$139.19$695,950.00View SEC Filing  
9/24/2015Martine A. RothblattCEOSell9,662$139.26$1,345,530.12View SEC Filing  
9/23/2015Martine A. RothblattCEOSell2,211$142.05$314,072.55View SEC Filing  
9/21/2015Martine A. RothblattCEOSell2,592$150.81$390,899.52View SEC Filing  
9/17/2015Martine A. RothblattCEOSell9,662$152.02$1,468,817.24View SEC Filing  
9/16/2015Martine A. RothblattCEOSell2,211$151.93$335,917.23View SEC Filing  
9/14/2015Martine A. RothblattCEOSell2,592$153.08$396,783.36View SEC Filing  
9/10/2015Martine A. RothblattCEOSell4,115$152.95$629,389.25View SEC Filing  
9/9/2015Martine A. RothblattCEOSell2,211$152.77$337,774.47View SEC Filing  
9/8/2015Martine A. RothblattCEOSell2,592$152.80$396,057.60View SEC Filing  
9/3/2015Martine A. RothblattCEOSell9,662$153.67$1,484,759.54View SEC Filing  
9/3/2015Raymond DwekDirectorSell3,000$155.54$466,620.00View SEC Filing  
9/2/2015Martine A. RothblattCEOSell2,211$151.12$334,126.32View SEC Filing  
8/31/2015Martine A. RothblattCEOSell2,592$153.50$397,872.00View SEC Filing  
8/27/2015Martine A. RothblattCEOSell9,662$160.37$1,549,494.94View SEC Filing  
8/26/2015Martine A. RothblattCEOSell2,211$155.47$343,744.17View SEC Filing  
8/24/2015Martine A. RothblattCEOSell2,592$155.36$402,693.12View SEC Filing  
8/20/2015Martine A. RothblattCEOSell9,662$166.58$1,609,495.96View SEC Filing  
8/19/2015Martine A. RothblattCEOSell2,211$167.13$369,524.43View SEC Filing  
8/17/2015Martine A RothblattCEOSell2,592$166.61$431,853.12View SEC Filing  
8/13/2015Martine A RothblattCEOSell9,662$165.05$1,594,713.10View SEC Filing  
7/27/2015Martine A RothblattCEOSell2,592$166.38$431,256.96View SEC Filing  
7/23/2015Martine A RothblattCEOSell4,115$176.38$725,803.70View SEC Filing  
7/22/2015Martine A RothblattCEOSell2,211$174.55$385,930.05View SEC Filing  
7/20/2015Martine A RothblattCEOSell2,592$177.92$461,168.64View SEC Filing  
7/16/2015Martine A RothblattCEOSell9,662$175.51$1,695,777.62View SEC Filing  
7/15/2015Martine A RothblattCEOSell2,211$176.77$390,838.47View SEC Filing  
7/13/2015Martine A RothblattCEOSell2,592$172.42$446,912.64View SEC Filing  
7/9/2015Martine A RothblattCEOSell9,662$168.04$1,623,602.48View SEC Filing  
7/8/2015Martine A RothblattCEOSell2,211$167.13$369,524.43View SEC Filing  
7/6/2015Martine A RothblattCEOSell2,592$170.66$442,350.72View SEC Filing  
7/2/2015Martine A RothblattCEOSell6,326$170.69$1,079,784.94View SEC Filing  
7/2/2015Raymond DwekDirectorSell3,000$171.59$514,770.00View SEC Filing  
6/29/2015Martine A RothblattCEOSell2,592$172.86$448,053.12View SEC Filing  
6/25/2015Martine A RothblattCEOSell9,662$176.91$1,709,304.42View SEC Filing  
6/24/2015Martine A RothblattCEOSell2,211$179.68$397,272.48View SEC Filing  
6/22/2015Martine A RothblattCEOSell2,592$188.64$488,954.88View SEC Filing  
6/18/2015Louis W SullivanDirectorSell15,000$185.60$2,784,000.00View SEC Filing  
6/18/2015Martine A RothblattCEOSell9,662$185.72$1,794,426.64View SEC Filing  
6/17/2015Martine A RothblattCEOSell2,211$185.25$409,587.75View SEC Filing  
6/15/2015Martine A RothblattCEOSell2,592$185.15$479,908.80View SEC Filing  
6/11/2015Martine A RothblattCEOSell9,662$183.76$1,775,489.12View SEC Filing  
6/10/2015Martine A RothblattCEOSell2,211$180.87$399,903.57View SEC Filing  
6/8/2015Martine A RothblattCEOSell2,592$181.34$470,033.28View SEC Filing  
6/4/2015Martine A RothblattCEOSell9,662$181.94$1,757,904.28View SEC Filing  
6/4/2015Raymond DwekDirectorSell3,000$181.36$544,080.00View SEC Filing  
6/3/2015Martine A RothblattCEOSell2,211$184.49$407,907.39View SEC Filing  
6/1/2015Martine A RothblattCEOSell2,592$182.66$473,454.72View SEC Filing  
5/28/2015Martine A RothblattCEOSell9,662$180.88$1,747,662.56View SEC Filing  
5/27/2015Martine A RothblattCEOSell2,211$184.39$407,686.29View SEC Filing  
5/26/2015Martine A RothblattCEOSell2,592$182.64$473,402.88View SEC Filing  
5/21/2015Martine A RothblattCEOSell9,662$182.44$1,762,735.28View SEC Filing  
5/21/2015Tommy G ThompsonDirectorSell1,500$182.04$273,060.00View SEC Filing  
5/20/2015Martine A RothblattCEOSell2,211$182.80$404,170.80View SEC Filing  
5/18/2015Martine A RothblattCEOSell2,592$177.79$460,831.68View SEC Filing  
5/14/2015Martine A RothblattCEOSell9,662$174.07$1,681,864.34View SEC Filing  
5/13/2015Martine A RothblattCEOSell2,211$175.41$387,831.51View SEC Filing  
5/11/2015Martine A RothblattCEOSell2,592$179.55$465,393.60View SEC Filing  
5/7/2015Christopher CauseyDirectorSell1,500$167.94$251,910.00View SEC Filing  
5/7/2015Martine A RothblattCEOSell9,662$169.86$1,641,187.32View SEC Filing  
5/6/2015Martine A RothblattCEOSell2,211$169.22$374,145.42View SEC Filing  
5/4/2015Martine A RothblattCEOSell2,592$169.81$440,147.52View SEC Filing  
5/1/2015Raymond DwekDirectorSell3,000$159.58$478,740.00View SEC Filing  
4/30/2015Martine A RothblattCEOSell9,662$162.36$1,568,722.32View SEC Filing  
4/29/2015Martine A RothblattCEOSell2,211$164.29$363,245.19View SEC Filing  
4/28/2015Roger JeffsCEOSell5,000$163.31$816,550.00View SEC Filing  
4/27/2015Martine A RothblattCEOSell2,592$177.62$460,391.04View SEC Filing  
4/23/2015Martine A RothblattCEOSell9,662$187.35$1,810,175.70View SEC Filing  
4/22/2015Martine A RothblattCEOSell2,211$187.49$414,540.39View SEC Filing  
4/21/2015Roger JeffsCEOSell10,000$187.86$1,878,600.00View SEC Filing  
4/20/2015Martine A RothblattCEOSell2,592$184.86$479,157.12View SEC Filing  
4/16/2015Martine A RothblattCEOSell11,873$187.01$2,220,369.73View SEC Filing  
4/16/2015Paul A MahonEVPSell6,000$187.91$1,127,460.00View SEC Filing  
4/14/2015David ZaccardelliCOOSell3,250$185.82$603,915.00View SEC Filing  
4/14/2015Roger JeffsCEOSell10,000$185.82$1,858,200.00View SEC Filing  
4/13/2015Martine A RothblattCEOSell2,592$187.86$486,933.12View SEC Filing  
4/9/2015David ZaccardelliCOOSell4,000$184.84$739,360.00View SEC Filing  
4/9/2015Martine A RothblattCEOSell9,662$183.09$1,769,015.58View SEC Filing  
4/8/2015Martine A RothblattCEOSell2,211$181.91$402,203.01View SEC Filing  
4/7/2015David ZaccardelliCOOSell4,000$179.34$717,360.00View SEC Filing  
4/7/2015Roger JeffsCEOSell10,000$179.34$1,793,400.00View SEC Filing  
4/6/2015Martine A RothblattCEOSell2,592$176.20$456,710.40View SEC Filing  
4/2/2015David ZaccardelliCOOSell4,000$174.73$698,920.00View SEC Filing  
4/2/2015Martine A RothblattCEOSell11,873$173.43$2,059,134.39View SEC Filing  
4/2/2015Paul A MahonEVPSell6,000$174.73$1,048,380.00View SEC Filing  
4/2/2015Raymond DwekDirectorSell3,000$175.49$526,470.00View SEC Filing  
3/30/2015Martine A RothblattCEOSell2,592$177.22$459,354.24View SEC Filing  
3/26/2015David ZaccardelliCOOSell4,000$167.52$670,080.00View SEC Filing  
3/26/2015Martine A RothblattCEOSell9,662$167.03$1,613,843.86View SEC Filing  
3/25/2015Martine A RothblattCEOSell2,211$173.67$383,984.37View SEC Filing  
3/24/2015David ZaccardelliCOOSell4,500$179.51$807,795.00View SEC Filing  
3/23/2015Martine A RothblattCEOSell2,592$177.76$460,753.92View SEC Filing  
3/19/2015Paul A MahonEVPSell6,000$175.82$1,054,920.00View SEC Filing  
3/18/2015Martine A RothblattCEOSell2,211$174.64$386,129.04View SEC Filing  
3/17/2015David ZaccardelliCOOSell4,000$177.34$709,360.00View SEC Filing  
3/16/2015Martine A RothblattCEOSell2,592$170.97$443,154.24View SEC Filing  
3/12/2015Martine A RothblattCEOSell11,873$162.94$1,934,586.62View SEC Filing  
3/10/2015Roger JeffsCEOSell18,750$143.68$2,694,000.00View SEC Filing  
3/9/2015Martine A RothblattCEOSell2,592$160.51$416,041.92View SEC Filing  
3/5/2015Martine A RothblattCEOSell9,662$159.75$1,543,504.50View SEC Filing  
3/5/2015Raymond DwekDirectorSell3,000$157.59$472,770.00View SEC Filing  
3/4/2015Martine A RothblattCEOSell2,211$157.63$348,519.93View SEC Filing  
3/3/2015Roger JeffsCEOSell10,000$157.74$1,577,400.00View SEC Filing  
3/2/2015Martine A RothblattCEOSell2,592$155.32$402,589.44View SEC Filing  
2/27/2015Ray KurzweilDirectorSell15,000$155.05$2,325,750.00View SEC Filing  
2/26/2015Martine A RothblattCEOSell9,662$155.23$1,499,832.26View SEC Filing  
2/25/2015Martine A RothblattCEOSell2,211$159.35$352,322.85View SEC Filing  
2/24/2015David ZaccardelliCOOSell1,458$155.16$226,223.28View SEC Filing  
2/24/2015Roger JeffsCEOSell10,000$155.16$1,551,600.00View SEC Filing  
2/23/2015Martine A RothblattCEOSell2,592$156.08$404,559.36View SEC Filing  
2/19/2015John Maxim FerrariCFOSell10,000$155.72$1,557,200.00View SEC Filing  
2/19/2015Martine A RothblattCEOSell9,662$155.99$1,507,175.38View SEC Filing  
2/19/2015Paul A MahonEVPSell6,000$155.72$934,320.00View SEC Filing  
2/17/2015David ZaccardelliCOOSell4,000$155.14$620,560.00View SEC Filing  
2/17/2015Martine A RothblattCEOSell2,592$152.28$394,709.76View SEC Filing  
2/12/2015Martine A RothblattCEOSell9,662$146.01$1,410,748.62View SEC Filing  
2/11/2015Martine A RothblattCEOSell2,211$147.29$325,658.19View SEC Filing  
2/10/2015David ZaccardelliCOOSell4,000$146.68$586,720.00View SEC Filing  
2/10/2015Roger JeffsCEOSell10,000$146.68$1,466,800.00View SEC Filing  
2/9/2015Martine A RothblattCEOSell2,592$143.32$371,485.44View SEC Filing  
2/5/2015John Maxim FerrariCFOSell10,000$141.92$1,419,200.00View SEC Filing  
2/5/2015Martine A RothblattCEOSell11,773$141.07$1,660,817.11View SEC Filing  
2/5/2015Paul A MahonEVPSell6,000$141.92$851,520.00View SEC Filing  
2/5/2015Raymond DwekDirectorSell3,000$140.41$421,230.00View SEC Filing  
2/3/2015David ZaccardelliCOOSell4,000$141.99$567,960.00View SEC Filing  
2/3/2015Roger JeffsCEOSell10,000$141.99$1,419,900.00View SEC Filing  
1/29/2015Martine A RothblattCEOSell9,662$143.29$1,384,467.98View SEC Filing  
1/28/2015Martine A RothblattCEOSell2,211$145.49$321,678.39View SEC Filing  
1/27/2015David ZaccardelliCOOSell4,000$147.19$588,760.00View SEC Filing  
1/27/2015Roger JeffsCEOSell10,000$147.19$1,471,900.00View SEC Filing  
1/26/2015Martine A RothblattCEOSell2,592$145.89$378,146.88View SEC Filing  
1/22/2015Martine A RothblattCEOSell11,873$146.76$1,742,481.48View SEC Filing  
1/20/2015David ZaccardelliCOOSell4,000$146.48$585,920.00View SEC Filing  
1/20/2015Martine A RothblattCEOSell2,592$145.06$375,995.52View SEC Filing  
1/15/2015John Maxim FerrariCFOSell22,500$137.84$3,101,400.00View SEC Filing  
1/15/2015Martine A RothblattCEOSell9,662$137.51$1,328,621.62View SEC Filing  
1/15/2015Paul A MahonEVPSell6,000$137.84$827,040.00View SEC Filing  
1/14/2015Martine A RothblattCEOSell2,211$135.18$298,882.98View SEC Filing  
1/13/2015David ZaccardelliCOOSell3,000$134.71$404,130.00View SEC Filing  
1/13/2015Roger JeffsCEOSell10,000$134.71$1,347,100.00View SEC Filing  
1/12/2015Martine A RothblattCEOSell2,592$132.00$342,144.00View SEC Filing  
1/8/2015Christopher PatuskyDirectorSell5,000$128.13$640,650.00View SEC Filing  
1/8/2015Martine A RothblattCEOSell9,662$128.31$1,239,731.22View SEC Filing  
1/7/2015Martine A RothblattCEOSell2,211$126.04$278,674.44View SEC Filing  
1/6/2015David ZaccardelliCOOSell3,000$124.93$374,790.00View SEC Filing  
1/6/2015Roger JeffsCEOSell7,500$124.93$936,975.00View SEC Filing  
1/5/2015Martine A RothblattCEOSell2,592$126.88$328,872.96View SEC Filing  
1/2/2015Christopher CauseyDirectorSell3,000$129.25$387,750.00View SEC Filing  
1/2/2015Martine A RothblattCEOSell9,662$126.53$1,222,532.86View SEC Filing  
1/2/2015Paul A MahonEVPSell6,000$127.73$766,380.00View SEC Filing  
12/31/2014Martine A RothblattCEOSell2,211$131.35$290,414.85View SEC Filing  
12/30/2014Roger JeffsCEOSell10,000$130.80$1,308,000.00View SEC Filing  
12/29/2014Martine A RothblattCEOSell2,592$131.75$341,496.00View SEC Filing  
12/26/2014Martine A RothblattCEOSell9,662$131.85$1,273,934.70View SEC Filing  
12/24/2014Martine A RothblattCEOSell2,211$130.35$288,203.85View SEC Filing  
12/23/2014Roger JeffsCOOSell10,000$127.82$1,278,200.00View SEC Filing  
12/22/2014Martine A RothblattCEOSell2,592$133.45$345,902.40View SEC Filing  
12/19/2014Christopher CauseyDirectorSell1,500$131.47$197,205.00View SEC Filing  
12/18/2014John Maxim FerrariCFOSell10,000$131.11$1,311,100.00View SEC Filing  
12/18/2014Martine A RothblattCEOSell9,662$129.06$1,246,977.72View SEC Filing  
12/18/2014Paul A MahonEVPSell10,750$130.03$1,397,822.50View SEC Filing  
12/17/2014Martine A RothblattCEOSell2,211$126.04$278,674.44View SEC Filing  
12/15/2014Martine A RothblattCEOSell2,592$129.75$336,312.00View SEC Filing  
12/11/2014Martine A RothblattCEOSell9,662$130.98$1,265,528.76View SEC Filing  
12/10/2014Martine A RothblattCEOSell2,211$132.77$293,554.47View SEC Filing  
12/9/2014Roger JeffsCOOSell10,000$134.80$1,348,000.00View SEC Filing  
12/8/2014Martine A RothblattCEOSell2,592$132.34$343,025.28View SEC Filing  
12/4/2014John Maxim FerrariCFOSell10,000$129.05$1,290,500.00View SEC Filing  
12/4/2014Martine A RothblattCEOSell11,873$131.32$1,559,162.36View SEC Filing  
12/4/2014Paul A MahonEVPSell11,000$129.92$1,429,120.00View SEC Filing  
12/4/2014Raymond DwekDirectorSell3,000$131.58$394,740.00View SEC Filing  
12/2/2014Roger JeffsCOOSell10,000$133.63$1,336,300.00View SEC Filing  
12/1/2014Martine A RothblattCEOSell2,592$132.92$344,528.64View SEC Filing  
11/28/2014Martine A RothblattCEOSell11,873$132.77$1,576,378.21View SEC Filing  
11/25/2014Roger JeffsCOOSell10,000$131.30$1,313,000.00View SEC Filing  
11/24/2014Martine A RothblattCEOSell2,592$130.72$338,826.24View SEC Filing  
11/21/2014Roger JeffsCOOSell10,000$130.15$1,301,500.00View SEC Filing  
11/20/2014Christopher CauseyDirectorSell1,500$127.20$190,800.00View SEC Filing  
11/20/2014John Maxim FerrariCFOSell10,000$129.22$1,292,200.00View SEC Filing  
11/20/2014Martine A RothblattCEOSell9,662$128.86$1,245,045.32View SEC Filing  
11/20/2014Paul A MahonEVPSell11,000$129.02$1,419,220.00View SEC Filing  
11/19/2014Martine A RothblattCEOSell2,211$128.69$284,533.59View SEC Filing  
11/18/2014Roger JeffsCOOSell10,000$128.21$1,282,100.00View SEC Filing  
11/17/2014Martine A RothblattCEOSell2,592$125.65$325,684.80View SEC Filing  
11/13/2014Martine A RothblattCEOSell9,662$124.79$1,205,720.98View SEC Filing  
11/12/2014Martine A RothblattCEOSell2,211$122.88$271,687.68View SEC Filing  
11/10/2014Martine A RothblattCEOSell2,592$125.14$324,362.88View SEC Filing  
11/7/2014Christopher PatuskyDirectorSell5,000$124.49$622,450.00View SEC Filing  
11/7/2014Roger JeffsCOOSell10,000$124.46$1,244,600.00View SEC Filing  
11/6/2014Christopher CauseyDirectorSell1,500$122.89$184,335.00View SEC Filing  
11/6/2014Martine A RothblattCEOSell4,115$125.33$515,732.95View SEC Filing  
11/6/2014Paul A MahonEVPSell5,000$125.02$625,100.00View SEC Filing  
11/5/2014Martine A RothblattCEOSell2,211$124.31$274,849.41View SEC Filing  
11/3/2014Martine A RothblattCEOSell2,592$127.49$330,454.08View SEC Filing  
10/30/2014Martine A RothblattCEOSell9,662$130.42$1,260,118.04View SEC Filing  
10/29/2014Martine A RothblattCEOSell2,211$131.10$289,862.10View SEC Filing  
10/27/2014Martine A RothblattCEOSell2,592$132.16$342,558.72View SEC Filing  
10/23/2014Martine A RothblattCEOSell11,873$129.97$1,543,133.81View SEC Filing  
10/23/2014Paul A MahonEVPSell11,000$127.04$1,397,440.00View SEC Filing  
10/13/2014Martine A RothblattCEOSell2,592$124.31$322,211.52View SEC Filing  
10/9/2014Martine A RothblattCEOSell9,662$129.97$1,255,770.14View SEC Filing  
10/9/2014Paul A MahonEVPSell5,000$130.59$652,950.00View SEC Filing  
10/8/2014Martine A RothblattCEOSell2,211$131.50$290,746.50View SEC Filing  
10/7/2014Roger JeffsCOOSell35,000$130.14$4,554,900.00View SEC Filing  
10/6/2014Martine A RothblattCEOSell2,592$129.32$335,197.44View SEC Filing  
10/3/2014Roger JeffsCOOSell10,000$129.79$1,297,900.00View SEC Filing  
10/2/2014Christopher CauseyDirectorSell1,500$130.65$195,975.00View SEC Filing  
10/2/2014John Maxim FerrariCFOSell10,000$129.46$1,294,600.00View SEC Filing  
10/2/2014Martine A RothblattCEOSell9,662$127.72$1,234,030.64View SEC Filing  
10/2/2014Paul A MahonEVPSell6,000$129.46$776,760.00View SEC Filing  
10/1/2014Martine A RothblattCEOSell2,211$127.40$281,681.40View SEC Filing  
9/30/2014Roger JeffsCOOSell20,000$128.65$2,573,000.00View SEC Filing  
9/25/2014Martine A RothblattCEOSell5,547$134.26$744,740.22View SEC Filing  
9/25/2014Paul A MahonEVPSell5,000$133.77$668,850.00View SEC Filing  
9/25/2014Richard GiltnerDirectorSell20,000$134.94$2,698,800.00View SEC Filing  
9/23/2014Roger JeffsCOOSell50,000$131.02$6,551,000.00View SEC Filing  
9/19/2014Roger JeffsCOOSell10,000$129.60$1,296,000.00View SEC Filing  
9/18/2014John Maxim FerrariCFOSell10,000$130.93$1,309,300.00View SEC Filing  
9/18/2014Martine A RothblattCEOSell9,662$127.35$1,230,455.70View SEC Filing  
9/18/2014Paul A MahonEVPSell6,000$130.93$785,580.00View SEC Filing  
9/17/2014Roger JeffsCOOSell20,000$127.01$2,540,200.00View SEC Filing  
9/15/2014Martine A RothblattCEOSell50,000$124.52$6,226,000.00View SEC Filing  
9/11/2014Martine A RothblattCEOSell9,662$120.79$1,167,072.98View SEC Filing  
9/11/2014Paul A MahonEVPSell5,000$120.70$603,500.00View SEC Filing  
9/10/2014Martine A RothblattCEOSell50,000$120.01$6,000,500.00View SEC Filing  
9/10/2014Richard GiltnerDirectorSell20,000$119.95$2,399,000.00View SEC Filing  
9/5/2014Roger JeffsCOOSell10,000$111.29$1,112,900.00View SEC Filing  
9/4/2014John Maxim FerrariCFOSell10,000$112.38$1,123,800.00View SEC Filing  
9/4/2014Martine A RothblattCEOSell9,662$112.87$1,090,549.94View SEC Filing  
9/4/2014Paul A MahonEVPSell6,000$112.38$674,280.00View SEC Filing  
9/4/2014Raymond DwekDirectorSell3,000$113.40$340,200.00View SEC Filing  
8/28/2014Martine A RothblattCEOSell7,014$92.46$648,514.44View SEC Filing  
8/28/2014Paul A MahonEVPSell5,000$92.07$460,350.00View SEC Filing  
8/21/2014John Maxim FerrariCFOSell10,000$93.75$937,500.00View SEC Filing  
8/21/2014Martine A RothblattCEOSell9,640$93.13$897,773.20View SEC Filing  
8/15/2014Christopher CauseyDirectorSell1,500$91.14$136,710.00View SEC Filing  
8/14/2014Martine A RothblattCEOSell4,115$88.39$363,724.85View SEC Filing  
8/14/2014Paul A MahonEVPSell10,000$88.41$884,100.00View SEC Filing  
8/7/2014Christopher PatuskyDirectorSell5,000$88.23$441,150.00View SEC Filing  
8/7/2014John Maxim FerrariCFOSell10,000$86.44$864,400.00View SEC Filing  
8/7/2014Martine A RothblattCEOSell4,115$88.40$363,766.00View SEC Filing  
8/1/2014Raymond DwekDirectorSell3,000$89.52$268,560.00View SEC Filing  
8/1/2014Roger JeffsCOOSell10,000$89.88$898,800.00View SEC Filing  
7/31/2014Martine A RothblattCEOSell3,933$90.95$357,706.35View SEC Filing  
7/29/2014Roger JeffsCOOSell50,000$96.25$4,812,500.00View SEC Filing  
7/25/2014Roger JeffsCOOSell10,000$91.54$915,400.00View SEC Filing  
7/24/2014Martine A RothblattCEOSell9,228$93.15$859,588.20View SEC Filing  
7/17/2014John Maxim FerrariCFOSell10,000$89.74$897,400.00View SEC Filing  
7/17/2014Martine A RothblattCEOSell3,833$90.87$348,304.71View SEC Filing  
7/11/2014Roger JeffsCOOSell10,000$93.06$930,600.00View SEC Filing  
7/10/2014Martine A RothblattCEOSell9,187$92.33$848,235.71View SEC Filing  
7/3/2014Christopher CauseyDirectorSell1,500$91.62$137,430.00View SEC Filing  
7/3/2014John Maxim FerrariCFOSell10,000$90.58$905,800.00View SEC Filing  
7/3/2014Martine A RothblattCEOSell3,833$91.37$350,221.21View SEC Filing  
6/26/2014Martine A RothblattCEOSell3,833$87.23$334,352.59View SEC Filing  
6/20/2014Roger JeffsCOOSell10,000$87.00$870,000.00View SEC Filing  
6/19/2014John Maxim FerrariCFOSell10,000$87.02$870,200.00View SEC Filing  
6/19/2014Martine A RothblattCEOSell3,833$85.68$328,411.44View SEC Filing  
6/19/2014Paul A MahonEVPSell2,000$85.67$171,340.00View SEC Filing  
6/12/2014Martine A RothblattCEOSell9,066$98.22$890,462.52View SEC Filing  
6/10/2014Roger JeffsCOOSell10,000$96.29$962,900.00View SEC Filing  
6/9/2014Roger JeffsCOOSell10,000$96.32$963,200.00View SEC Filing  
6/5/2014Christopher CauseyDirectorSell1,500$96.48$144,720.00View SEC Filing  
6/5/2014Martine A RothblattCEOSell9,066$96.46$874,506.36View SEC Filing  
6/5/2014Paul A MahonEVPSell6,000$96.50$579,000.00View SEC Filing  
6/3/2014Roger JeffsCOOSell10,000$95.00$950,000.00View SEC Filing  
5/29/2014Martine A RothblattCEOSell9,066$95.27$863,717.82View SEC Filing  
5/27/2014Roger JeffsCOOSell10,000$99.14$991,400.00View SEC Filing  
5/22/2014Louis SullivanDirectorSell30,000$101.46$3,043,800.00View SEC Filing  
5/22/2014Martine RothblattCEOSell9,066$101.35$918,839.10View SEC Filing  
5/20/2014Roger JeffsCOOSell10,000$99.91$999,100.00View SEC Filing  
5/16/2014Roger JeffsCOOSell10,000$100.00$1,000,000.00View SEC Filing  
5/15/2014John Maxim FerrariCFOSell10,000$101.49$1,014,900.00View SEC Filing  
5/15/2014Martine RothblattCEOSell9,066$100.88$914,578.08View SEC Filing  
5/15/2014Paul MahonEVPSell6,000$100.86$605,160.00View SEC Filing  
5/13/2014Roger JeffsCOOSell10,000$105.53$1,055,300.00View SEC Filing  
5/8/2014Christopher PatuskyDirectorSell5,000$107.17$535,850.00View SEC Filing  
5/8/2014Martine RothblattCEOSell9,066$107.83$977,586.78View SEC Filing  
5/6/2014Roger JeffsCOOSell10,000$106.50$1,065,000.00View SEC Filing  
5/2/2014Roger JeffsCOOSell10,000$102.00$1,020,000.00View SEC Filing  
5/1/2014Christopher CauseyDirectorSell1,500$99.30$148,950.00View SEC Filing  
5/1/2014John Maxim FerrariCFOSell10,000$102.20$1,022,000.00View SEC Filing  
5/1/2014Martine RothblattCEOSell9,066$101.84$923,281.44View SEC Filing  
5/1/2014Paul MahonEVPSell6,000$102.71$616,260.00View SEC Filing  
4/29/2014Roger JeffsCOOSell10,000$95.00$950,000.00View SEC Filing  
4/24/2014Martine RothblattCEOSell9,066$92.45$838,151.70View SEC Filing  
4/22/2014Roger JeffsCOOSell10,000$96.00$960,000.00View SEC Filing  
4/17/2014John Maxim FerrariCFOSell10,000$96.20$962,000.00View SEC Filing  
4/17/2014Martine RothblattCEOSell9,066$98.48$892,819.68View SEC Filing  
4/17/2014Paul MahonEVPSell6,000$98.37$590,220.00View SEC Filing  
4/15/2014Roger JeffsCOOSell10,000$95.06$950,600.00View SEC Filing  
4/10/2014Martine RothblattCEOSell9,066$96.18$871,967.88View SEC Filing  
4/8/2014Roger JeffsCOOSell10,000$95.00$950,000.00View SEC Filing  
4/4/2014Roger JeffsCOOSell10,000$93.22$932,200.00View SEC Filing  
4/3/2014Christopher CauseyDirectorSell1,500$95.67$143,505.00View SEC Filing  
4/3/2014John Maxim FerrariCFOSell10,000$93.22$932,200.00View SEC Filing  
4/3/2014Martine RothblattCEOSell9,066$93.74$849,846.84View SEC Filing  
4/3/2014Paul MahonEVPSell6,000$93.10$558,600.00View SEC Filing  
4/1/2014Roger JeffsCOOSell10,000$95.44$954,400.00View SEC Filing  
3/27/2014Martine RothblattCEOSell9,066$93.35$846,311.10View SEC Filing  
3/25/2014Roger JeffsCOOSell10,000$95.64$956,400.00View SEC Filing  
3/21/2014Roger JeffsCOOSell10,000$93.84$938,400.00View SEC Filing  
3/20/2014Christopher CauseyDirectorSell1,500$96.04$144,060.00View SEC Filing  
3/20/2014John Maxim FerrariCFOSell10,000$96.11$961,100.00View SEC Filing  
3/20/2014Martine RothblattCEOSell9,065$96.76$877,129.40View SEC Filing  
3/20/2014Paul MahonEVPSell6,000$96.81$580,860.00View SEC Filing  
3/18/2014Roger JeffsCOOSell10,000$96.51$965,100.00View SEC Filing  
3/13/2014Martine RothblattCEOSell3,833$95.64$366,588.12View SEC Filing  
3/7/2014Roger JeffsCOOSell10,000$99.02$990,200.00View SEC Filing  
3/6/2014Christopher PatuskyDirectorSell5,000$101.39$506,950.00View SEC Filing  
3/6/2014John Maxim FerrariCFOSell10,000$99.07$990,700.00View SEC Filing  
3/6/2014Martine RothblattCEOSell3,833$102.77$393,917.41View SEC Filing  
3/6/2014Paul MahonEVPSell6,000$101.93$611,580.00View SEC Filing  
2/28/2014Ray KurzweilDirectorSell15,000$101.42$1,521,300.00View SEC Filing  
2/27/2014Martine RothblattCEOSell3,833$100.68$385,906.44View SEC Filing  
2/21/2014Roger JeffsCOOSell10,000$104.89$1,048,900.00View SEC Filing  
2/20/2014Martine RothblattCEOSell3,833$103.91$398,287.03View SEC Filing  
2/20/2014Paul MahonEVPSell6,000$104.63$627,780.00View SEC Filing  
2/13/2014Martine RothblattCEOSell3,833$99.87$382,801.71View SEC Filing  
2/7/2014Roger JeffsCOOSell10,000$96.61$966,100.00View SEC Filing  
2/6/2014Martine RothblattCEOSell3,833$97.26$372,797.58View SEC Filing  
2/6/2014Paul MahonEVPSell6,000$97.41$584,460.00View SEC Filing  
2/6/2014Raymond DwekDirectorSell3,000$97.33$291,990.00View SEC Filing  
1/30/2014Martine RothblattCEOSell3,833$106.25$407,256.25View SEC Filing  
1/23/2014Martine RothblattCEOSell3,833$111.78$428,452.74View SEC Filing  
1/17/2014Roger JeffsCOOSell10,000$113.03$1,130,300.00View SEC Filing  
1/16/2014Martine RothblattCEOSell3,833$111.21$426,267.93View SEC Filing  
1/16/2014Paul MahonEVPSell6,000$111.98$671,880.00View SEC Filing  
1/9/2014Christopher PatuskyDirectorSell5,000$110.00$550,000.00View SEC Filing  
1/9/2014Martine RothblattCEOSell3,833$108.35$415,305.55View SEC Filing  
1/3/2014Roger JeffsCOOSell10,000$110.72$1,107,200.00View SEC Filing  
1/2/2014Martine RothblattCEOSell3,833$111.54$427,532.82View SEC Filing  
1/2/2014Paul MahonEVPSell6,000$110.78$664,680.00View SEC Filing  
1/2/2014Raymond DwekDirectorSell3,000$111.41$334,230.00View SEC Filing  
12/31/2013Martine RothblattCEOSell18,140$112.64$2,043,289.60View SEC Filing  
12/30/2013Martine RothblattCEOSell18,147$111.60$2,025,205.20View SEC Filing  
12/27/2013Martine RothblattCEOSell18,147$113.15$2,053,333.05View SEC Filing  
12/26/2013Martine RothblattCEOSell21,981$111.95$2,460,772.95View SEC Filing  
12/24/2013Martine RothblattCEOSell18,149$114.05$2,069,893.45View SEC Filing  
12/23/2013Martine RothblattCEOSell5,743$109.71$630,064.53View SEC Filing  
12/20/2013Martine RothblattCEOSell18,149$86.72$1,573,881.28View SEC Filing  
12/20/2013Roger JeffsCOOSell8,250$87.84$724,680.00View SEC Filing  
12/19/2013Martine RothblattCEOSell21,982$86.73$1,906,498.86View SEC Filing  
12/19/2013Paul MahonEVPSell6,000$86.45$518,700.00View SEC Filing  
12/18/2013Martine RothblattCEOSell18,149$86.36$1,567,347.64View SEC Filing  
12/17/2013Martine RothblattCEOSell12,251$86.49$1,059,588.99View SEC Filing  
12/6/2013Roger JeffsCOOSell10,000$90.97$909,700.00View SEC Filing  
12/5/2013Martine RothblattCEOSell3,833$89.79$344,165.07View SEC Filing  
12/5/2013Paul MahonEVPSell6,000$89.18$535,080.00View SEC Filing  
12/5/2013Raymond DwekDirectorSell3,000$90.13$270,390.00View SEC Filing  
11/21/2013Martine RothblattCEOSell3,833$92.49$354,514.17View SEC Filing  
11/21/2013Paul MahonEVPSell6,000$92.47$554,820.00View SEC Filing  
11/15/2013Roger JeffsCOOSell10,000$94.00$940,000.00View SEC Filing  
11/14/2013Christopher PatuskyDirectorSell5,500$91.65$504,075.00View SEC Filing  
11/14/2013Martine RothblattCEOSell3,833$91.60$351,102.80View SEC Filing  
11/7/2013Christopher PatuskyDirectorSell3,500$90.51$316,785.00View SEC Filing  
11/7/2013Martine RothblattCEOSell3,833$89.47$342,938.51View SEC Filing  
11/7/2013Paul MahonEVPSell6,000$89.60$537,600.00View SEC Filing  
11/1/2013Raymond DwekDirectorSell3,000$89.18$267,540.00View SEC Filing  
11/1/2013Roger JeffsCOOSell10,000$90.34$903,400.00View SEC Filing  
10/31/2013Martine A RothblattCEOSell3,833$86.89$333,049.37View SEC Filing  
10/24/2013Martine A RothblattCEOSell3,833$83.77$321,090.41View SEC Filing  
10/18/2013Roger JeffsCOOSell10,000$82.47$824,700.00View SEC Filing  
10/17/2013John Maxim FerrariCFOSell2,750$82.01$225,527.50View SEC Filing  
10/17/2013Martine A RothblattCEOSell3,833$81.84$313,692.72View SEC Filing  
10/17/2013Paul A MahonEVPSell6,000$81.79$490,740.00View SEC Filing  
10/10/2013Martine RothblattCEOSell3,833$82.58$316,529.14View SEC Filing  
10/4/2013Roger JeffsCOOSell10,000$85.48$854,800.00View SEC Filing  
10/3/2013Christopher CauseyDirectorSell1,500$83.15$124,725.00View SEC Filing  
10/3/2013John Maxim FerrariCFOSell4,500$84.67$381,015.00View SEC Filing  
10/3/2013Martine A RothblattCEOSell3,833$84.20$322,738.60View SEC Filing  
10/3/2013Paul A MahonEVPSell6,000$84.38$506,280.00View SEC Filing  
9/26/2013Martine RothblattCEOSell3,833$78.41$300,545.53View SEC Filing  
9/20/2013Roger JeffsCOOSell10,000$77.86$778,600.00View SEC Filing  
9/19/2013John Maxim FerrariCFOSell4,500$78.67$354,015.00View SEC Filing  
9/19/2013Martine RothblattCEOSell3,833$78.12$299,433.96View SEC Filing  
9/19/2013Paul MahonEVPSell6,000$78.02$468,120.00View SEC Filing  
9/12/2013Martine A RothblattCEOSell3,833$76.98$295,064.34View SEC Filing  
9/6/2013Roger JeffsCOOSell10,000$73.67$736,700.00View SEC Filing  
9/5/2013Christopher CauseyDirectorSell1,500$73.11$109,665.00View SEC Filing  
9/5/2013John Maxim FerrariCFOSell4,500$74.17$333,765.00View SEC Filing  
9/5/2013Martine A RothblattCEOSell3,833$73.63$282,223.79View SEC Filing  
9/5/2013Paul A MahonEVPSell6,000$73.29$439,740.00View SEC Filing  
8/29/2013Martine RothblattCEOSell3,833$72.76$278,889.08View SEC Filing  
8/22/2013Martine RothblattCEOSell3,833$72.06$276,205.98View SEC Filing  
8/16/2013Roger JeffsCOOSell10,000$71.21$712,100.00View SEC Filing  
8/15/2013John Maxim FerrariCFOSell4,500$71.14$320,130.00View SEC Filing  
8/15/2013Martine RothblattCEOSell3,833$71.58$274,366.14View SEC Filing  
8/15/2013Paul MahonEVPSell6,000$71.34$428,040.00View SEC Filing  
8/8/2013Martine RothblattCEOSell3,833$73.11$280,230.63View SEC Filing  
8/2/2013Roger JeffsCOOSell10,000$76.69$766,900.00View SEC Filing  
8/1/2013John Maxim FerrariCFOSell4,500$75.87$341,415.00View SEC Filing  
8/1/2013Martine A RothblattCEOSell3,833$75.97$291,193.01View SEC Filing  
8/1/2013Paul A MahonEVPSell6,000$75.91$455,460.00View SEC Filing  
8/1/2013Raymond DwekDirectorSell3,000$75.94$227,820.00View SEC Filing  
7/31/2013R Paul GrayDirectorSell7,500$74.93$561,975.00View SEC Filing  
7/25/2013Martine A RothblattCEOSell3,833$71.45$273,867.85View SEC Filing  
7/19/2013Roger JeffsCOOSell10,000$70.00$700,000.00View SEC Filing  
7/18/2013John Maxim FerrariCFOSell9,000$69.85$628,650.00View SEC Filing  
7/18/2013Martine A RothblattCEOSell3,833$68.96$264,323.68View SEC Filing  
7/18/2013Paul A MahonEVPSell6,000$69.15$414,900.00View SEC Filing  
7/11/2013Martine A RothblattCEOSell3,837$67.94$260,685.78View SEC Filing  
7/5/2013Christopher CauseyDirectorSell1,500$66.33$99,495.00View SEC Filing  
7/5/2013Martine A RothblattCEOSell3,863$67.28$259,902.64View SEC Filing  
7/5/2013Paul A MahonEVPSell6,000$67.04$402,240.00View SEC Filing  
7/5/2013Roger JeffsCOOSell10,000$67.21$672,100.00View SEC Filing  
6/21/2013Roger JeffsCOOSell10,000$63.34$633,400.00View SEC Filing  
6/20/2013John Maxim FerrariCFOSell4,500$63.22$284,490.00View SEC Filing  
6/20/2013Paul A MahonEVPSell6,000$63.29$379,740.00View SEC Filing  
6/7/2013Roger JeffsCOOSell10,000$67.00$670,000.00View SEC Filing  
6/6/2013John Maxim FerrariCFOSell4,500$64.84$291,780.00View SEC Filing  
6/6/2013Paul A MahonEVPSell6,000$63.84$383,040.00View SEC Filing  
6/6/2013Raymond DwekDirectorSell3,000$63.77$191,310.00View SEC Filing  
5/17/2013Roger JeffsCOOSell10,000$69.17$691,700.00View SEC Filing  
5/16/2013John Maxim FerrariCFOSell4,500$68.48$308,160.00View SEC Filing  
5/16/2013Paul A MahonEVPSell6,000$68.05$408,300.00View SEC Filing  
5/2/2013Paul A MahonEVPSell6,000$67.15$402,900.00View SEC Filing  
5/2/2013Raymond DwekDirectorSell3,000$66.75$200,250.00View SEC Filing  
4/11/2013Raymond DwekDirectorSell9,000$61.35$552,150.00View SEC Filing  
1/17/2013Paul A MahonEVPSell5,749$52.20$300,097.80View SEC Filing  
12/28/2012Martine A RothblattCEOBuy4,167$52.40$218,350.80View SEC Filing  
12/26/2012Martine A RothblattCEOBuy6,000$52.40$314,400.00View SEC Filing  
12/21/2012Martine A RothblattCEOBuy9,000$51.85$466,650.00View SEC Filing  
11/26/2012Christopher CauseyDirectorSell1,500$53.33$79,995.00View SEC Filing  
10/4/2012Christopher CauseyDirectorSell1,500$58.33$87,495.00View SEC Filing  
10/4/2012John Maxim FerrariCFOSell1,550$58.00$89,900.00View SEC Filing  
10/4/2012Paul A MahonEVPSell6,000$38.00$228,000.00View SEC Filing  
9/6/2012Christopher CauseyDirectorSell1,500$55.94$83,910.00View SEC Filing  
9/5/2012Christopher PatuskyDirectorSell2,000$55.47$110,940.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for United Therapeutics (NASDAQ:UTHR)
DateHeadline
realistinvestor.com logoUnited Therapeutics Corporation (NASDAQ:UTHR) Deferred Tax Assets At $14.554 Millions - RealistInvestor.com (NASDAQ:UTHR)
www.realistinvestor.com - February 21 at 4:26 PM
News IconInside the Numbers for United Therapeutics Corporation (NASDAQ:UTHR) - Providence Standard (NASDAQ:UTHR)
providencestandard.com - February 21 at 4:26 PM
News IconEPS Forecast Of United Therapeutics Corporation (NASDAQ:UTHR) Set At $3.4067 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - February 15 at 6:49 AM
finance.yahoo.com logoUnited Therapeutics Corporation To Report Fourth Quarter And Annual 2016 Financial Results Before The Market Opens On Wednesday, February 22, 2017 (NASDAQ:UTHR)
finance.yahoo.com - February 15 at 6:49 AM
realistinvestor.com logoThe Growth Forecast For United Therapeutics Corporation (NASDAQ:UTHR) (NASDAQ:UTHR)
www.realistinvestor.com - February 9 at 6:26 AM
finance.yahoo.com logoYour Guide To 2017's Emerging Pharmaceuticals Catalysts (NASDAQ:UTHR)
finance.yahoo.com - February 7 at 8:49 PM
realistinvestor.com logoUnited Therapeutics Corporation (NASDAQ:UTHR) Mean Rating At $2.4 - RealistInvestor.com (NASDAQ:UTHR)
www.realistinvestor.com - February 5 at 2:12 AM
News IconUnited Therapeutics Corporation (NASDAQ:UTHR) Mean Price Target At $137.6 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - February 5 at 2:12 AM
marketexclusive.com logoUnited Therapeutics Corporation (NASDAQ:UTHR) Files An 8-K Amendments to Articles of Incorporation or Bylaws ... - Market Exclusive (NASDAQ:UTHR)
marketexclusive.com - February 3 at 6:33 AM
News IconA Reversal for United Therapeutics Corporation (UTHR) Is Not Near. The Stock Reaches 52-Week High Today (NASDAQ:UTHR)
randolphguide.com - February 1 at 7:16 AM
News IconUnited Therapeutics Corporation (NASDAQ:UTHR) Target Price At $137.6 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - January 31 at 7:21 AM
seekingalpha.com logoUnited Therapeutics Corporation (UTHR) (NASDAQ:UTHR)
seekingalpha.com - January 30 at 10:26 AM
streetinsider.com logoUnited Therapeutics (UTHR) Orenitram Could See Tailwind from Uptravi Dear Doctor Letter in France - Wedbush - StreetInsider.com (NASDAQ:UTHR)
www.streetinsider.com - January 28 at 7:31 AM
realistinvestor.com logoAnalysts Rating Of United Therapeutics Corporation (NASDAQ:UTHR) At 2.4 - RealistInvestor.com (NASDAQ:UTHR)
www.realistinvestor.com - January 25 at 4:14 PM
us.rd.yahoo.com logoUnited Therapeutics downgraded by Standpoint Research (NASDAQ:UTHR)
us.rd.yahoo.com - January 19 at 9:18 PM
News IconUnited Therapeutics Corporation (NASDAQ:UTHR) Price Target Set At $137.6 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - January 19 at 4:15 PM
News IconSteady As She Goes, Accelerated Growth Puts Stock in Focus ... - Wall Street Beacon (NASDAQ:UTHR)
wsbeacon.com - January 19 at 4:15 PM
News IconWill The Needle Move For United Therapeutics Corporation (NASDAQ:UTHR) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:UTHR)
wsbeacon.com - January 19 at 4:15 PM
realistinvestor.com logoUnited Therapeutics Corporation (NASDAQ:UTHR) Analysts Rating At 2.4 (NASDAQ:UTHR)
www.realistinvestor.com - January 19 at 6:53 AM
realistinvestor.com logoUnited Therapeutics Corporation (NASDAQ:UTHR) Mean Rating At $2.4 (NASDAQ:UTHR)
www.realistinvestor.com - January 15 at 3:01 AM
marketexclusive.com logoInsider Trading Activity United Therapeutics Corporation (NASDAQ:UTHR) – CEO Sold 1,208 shares of Stock (NASDAQ:UTHR)
marketexclusive.com - January 9 at 3:50 AM
News IconNarrowing in on the Numbers for United Therapeutics Corporation (NASDAQ:UTHR) - Wall Street Beacon (NASDAQ:UTHR)
wsbeacon.com - January 7 at 6:20 AM
News IconPrice Target Of United Therapeutics Corporation (NASDAQ:UTHR) Agreed At $137.6 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - January 6 at 6:25 AM
finance.yahoo.com logoUnited Therapeutics Corporation To Present At 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:UTHR)
finance.yahoo.com - January 5 at 7:26 AM
News IconPrice Target Of United Therapeutics Corporation (NASDAQ:UTHR) At $137.6 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - January 2 at 3:32 PM
News IconEnterprise Value Review for United Therapeutics Corporation (NASDAQ:UTHR) - Wall Street Beacon (NASDAQ:UTHR)
wsbeacon.com - January 1 at 1:15 AM
News IconUnited Therapeutics Corporation (NASDAQ:UTHR) News Impact Score At 0 - Stock Observer (NASDAQ:UTHR)
www.thestockobserver.com - December 29 at 8:05 AM
marketexclusive.com logoInsider Trading Activity United Therapeutics Corp. (NASDAQ:UTHR) – CEO Sold 1,218 shares of Stock (NASDAQ:UTHR)
marketexclusive.com - December 25 at 7:40 PM
News IconStock Levels in View for United Therapeutics Corporation (NASDAQ:UTHR) - Wall Street Beacon (NASDAQ:UTHR)
wsbeacon.com - December 25 at 8:23 AM
marketexclusive.com logoInsider Trading Activity United Therapeutics Corp. (NASDAQ:UTHR ... - Market Exclusive (NASDAQ:UTHR)
marketexclusive.com - December 24 at 7:51 PM
News IconEPS Of United Therapeutics Corporation (NASDAQ:UTHR) Set At $3.62 - Stock Observer (NASDAQ:UTHR)
www.thestockobserver.com - December 24 at 8:01 AM
News IconUnited Therapeutics Corporation (NASDAQ:UTHR) EPS Estimate At $3.535 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - December 21 at 8:20 PM
News IconNews Impact Score Of United Therapeutics Corporation (NASDAQ:UTHR) At 58 - Stock Observer (NASDAQ:UTHR)
www.thestockobserver.com - December 21 at 8:20 PM
prnewswire.com logoResearch Reports Coverage on Drug Makers Stocks -- Depomed ... - PR Newswire (press release) (NASDAQ:UTHR)
www.prnewswire.com - December 21 at 3:20 PM
realistinvestor.com logoUnited Therapeutics Corporation (NASDAQ:UTHR) Analysts Rating At 2.4 - RealistInvestor.com (NASDAQ:UTHR)
www.realistinvestor.com - December 21 at 3:20 PM
News IconWatching the Levels on Shares of United Therapeutics Corporation ... - Marion Business Daily (NASDAQ:UTHR)
marionbusinessdaily.com - December 21 at 3:20 PM
News IconInvestor Focus: Watching Shares of United Therapeutics Corporation (NASDAQ:UTHR) - The Business Journal (NASDAQ:UTHR)
belmontbusinessjournal.com - December 19 at 1:31 AM
News IconVC Score Review for United Therapeutics Corporation (NASDAQ:UTHR) - Wall Street Beacon (NASDAQ:UTHR)
wsbeacon.com - December 19 at 1:31 AM
realistinvestor.com logoMean Rating Of United Therapeutics Corporation (NASDAQ:UTHR ... - RealistInvestor.com (NASDAQ:UTHR)
www.realistinvestor.com - December 18 at 3:58 AM
News IconStock Survey: Checking Levels for United Therapeutics Corporation (NASDAQ:UTHR) - OIB News (NASDAQ:UTHR)
oibnews.com - December 18 at 3:58 AM
streetinsider.com logoUPDATE: Oppenheimer Starts United Therapeutics Corp. (UTHR) at Outperform (NASDAQ:UTHR)
www.streetinsider.com - December 17 at 5:50 AM
News IconUnited Therapeutics Corporation (NASDAQ:UTHR) Price Target Agreed At $135.111 - Transcript Daily (NASDAQ:UTHR)
transcriptdaily.com - December 16 at 6:18 AM
streetinsider.com logoUPDATE: Oppenheimer Starts United Therapeutics Corp. (UTHR) at Outperform - StreetInsider.com (NASDAQ:UTHR)
www.streetinsider.com - December 16 at 6:18 AM
finance.yahoo.com logoCoverage initiated on United Therapeutics by Oppenheimer (NASDAQ:UTHR)
finance.yahoo.com - December 16 at 6:18 AM
News IconF-Score in Review on Shares of United Therapeutics Corporation (NASDAQ:UTHR) - Marion Business Daily (NASDAQ:UTHR)
marionbusinessdaily.com - December 13 at 7:37 AM
News IconStock Corner: Tracking Metrics for United Therapeutics Corporation (NASDAQ:UTHR) - Marion Business Daily (NASDAQ:UTHR)
marionbusinessdaily.com - December 12 at 8:26 AM
News IconInvestor Focus: Watching Shares of United Therapeutics Corporation (NASDAQ:UTHR) - Marion Business Daily (NASDAQ:UTHR)
marionbusinessdaily.com - December 11 at 8:22 AM
News IconInsider Move From SEC: United Therapeutics Corporation (NASDAQ:UTHR)’s director Richard Giltner Unloaded 5000 shares of the Company (NASDAQ:UTHR)
www.whatsonthorold.com - December 7 at 9:06 PM
stocksdaily.net logoWill United Therapeutics Corporation (NASDAQ:UTHR) Surprise Analysts This Quarter? (NASDAQ:UTHR)
www.stocksdaily.net - December 5 at 3:55 PM
News IconWhat The Charts Are Saying About United Therapeutics Corporation (NASDAQ:UTHR) - The Business Journal (NASDAQ:UTHR)
belmontbusinessjournal.com - December 2 at 10:35 AM

Social

What is United Therapeutics' stock symbol?

United Therapeutics trades on the NASDAQ under the ticker symbol "UTHR."

Where is United Therapeutics' stock going? Where will United Therapeutics' stock price be in 2017?

12 brokerages have issued 1 year price objectives for United Therapeutics' shares. Their predictions range from $95.00 to $229.00. On average, they anticipate United Therapeutics' share price to reach $134.18 in the next year.

When will United Therapeutics announce their earnings?

United Therapeutics is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.

What are analysts saying about United Therapeutics stock?

Here are some recent quotes from research analysts about United Therapeutics stock:

  • According to Zacks Investment Research, "United Therapeutics holds a strong position in the pulmonary arterial hypertension (PAH) market with four approved products targeting this indication. The company’s latest PAH offering, Orenitram, should continue to witness higher sales on the back of new patient starts, increasing patient referrals, and higher uptake in community centers. United Therapeutics’ shares outperformed the Drugs industry in the past one year. Meanwhile, we believe the company needs to use cash suitably to deal with generic competition for flagship product Remodulin that could materialize post Oct 2017 and work on expanding its portfolio. Nonetheless, the company is working on new delivery mechanisms and indications for its marketed products which might drive long-term growth. Estimates for 2017 have moved up lately ahead of Q4 earnings release. The company has a positive record of earnings surprises in recent quarters." (1/17/2017)

  • Jefferies Group LLC analysts commented, "Despite the impact seen in 2Q from competitor Uptravi, UTHR is confident of a rebound in Tyvaso/Orenitram sales going forward, citing waning Uptravi warehousing effect." However, we continue to be cautious on Uptravi competition & upcoming patent expiry (Remodulin generic entry beginning in mid-2018); we project a revenue CAGR of (5%) for 2015-2020. Approx. 5% higher 2Q16 revenue of ~$413M (vs. ours/cons $392M/$395M) driven by Remodulin & Adcirca (Chart 1). Approx. 3% higher treprostinil franchise sales included ~10%/9% higher Remodulin sales of $159M (vs. ours/cons $144M/$146M) likely due to variations in timing & magnitude of specialty distributors’ orders, flat/5% lower Tyvaso sales of $107M (vs. ours/cons $107M/$113M) despite a ~5% price increase on 4/30/16; & ~16%/12% lower Orenitram sales of $38M (vs. ours/cons $45M/$43M). UTHR attributed ~15%/21% higher Adcirca sales of ~$91M (vs." (7/29/2016)

Who owns United Therapeutics stock?

United Therapeutics' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (9.53%), Palo Alto Investors LLC (4.41%), State Street Corp (4.38%), AQR Capital Management LLC (3.20%), Thompson Siegel & Walmsley LLC (1.22%) and Dimensional Fund Advisors LP (1.06%). Company insiders that own United Therapeutics stock include Christopher Causey, Christopher Patusky, David Zaccardelli, Louis W Sullivan, Martine A Rothblatt, Paul A Mahon, Ray Kurzweil, Raymond Dwek, Richard Giltner, Roger Jeffs and Tommy G Thompson.

Who sold United Therapeutics stock? Who is selling United Therapeutics stock?

United Therapeutics' stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Oxford Asset Management, State Street Corp, Two Sigma Investments LP, Guggenheim Capital LLC, Federated Investors Inc. PA, Asset Management One Co. Ltd. and Thompson Siegel & Walmsley LLC. Company insiders that have sold United Therapeutics stock in the last year include Christopher Patusky, Martine A Rothblatt, Raymond Dwek, Richard Giltner and Tommy G Thompson.

Who bought United Therapeutics stock? Who is buying United Therapeutics stock?

United Therapeutics' stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Dimensional Fund Advisors LP, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Palo Alto Investors LLC, Frontier Capital Management Co. LLC, Flinton Capital Management LLC, Tyers Asset Management LLC and Renaissance Technologies LLC.

How do I buy United Therapeutics stock?

Shares of United Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of United Therapeutics stock cost?

One share of United Therapeutics stock can currently be purchased for approximately $167.92.

United Therapeutics (NASDAQ:UTHR) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for United Therapeutics (NASDAQ:UTHR)

Earnings History Chart

Earnings by Quarter for United Therapeutics (NASDAQ:UTHR)

Dividend History Chart

Dividend Payments by Quarter for United Therapeutics (NASDAQ:UTHR)

Last Updated on 2/22/2017 by MarketBeat.com Staff